
Atrosooth 0.6mg Injection
Marketer
Morepen Laboratories Ltd
Salt Composition
Atropine (0.6mg)
Overview Atrosooth 0.6mg Injection
Atrosooth 0.6mg Injection treats slow heartbeats (bradycardia) and helps restore normal rhythm during cardiac arrest. It's also administered pre-anesthesia to decrease saliva production and counteracts certain insecticide poisonings. This injection may be combined with other drugs to counteract muscle relaxant effects during operations. Dosage is determined and administered by a healthcare professional. Inform your doctor of all other medications you're using, as interactions are possible. Blurred vision, rapid heartbeat, and dry mouth (mitigated by frequent rinsing, good oral hygiene, and increased fluids) are potential side effects. Consult your physician before use if pregnant, breastfeeding, or with significant heart conditions or urinary retention.
Uses of Atrosooth 0.6mg Injection
Slow heart rate
Major Benefits of Atrosooth 0.6mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Atrosooth 0.6mg Injection:
- Injection site pain
How to use Atrosooth 0.6mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Atrosooth 0.6mg Injection works:
Atrosooth 0.6mg Injection, an anticholinergic agent, inhibits the action of the neurotransmitter acetylcholine. This mechanism reduces glandular secretions (such as saliva and sweat) pre-operatively, elevates bradycardia, and mitigates bowel spasms. Furthermore, it serves as a counteragent in specific intoxications and neutralizes the adverse effects of some muscle relaxants.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Atrosooth 0.6mg Injection and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Atrosooth 0.6mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Atrosooth (0.6mg) presents minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no apparent threat to the infant. Note that milk production might be reduced.
DrivingUNSAFE
Administering Atrosooth 0.6mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving is contraindicated if these side effects manifest.
KidneyCAUTION
Exercise caution when administering Atrosooth 0.6mg Injection to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should receive Atrosooth 0.6mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Atrosooth 0.6mg Injection :
For Atrosooth 0.6mg Injection, administer the missed dose promptly upon remembrance. If your next scheduled dose is imminent, omit the forgotten dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Atrosooth 0.6mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Naturally Occurring Alkaloids |
| Developing Habits | No. |
| Type of Therapy | Ophthalmology |
